This presentation delves into the critical challenges of bioassay development for multi-specific biologics, addressing key complexities. Experts from WuXi Biologics’ Bioassay Centre of Excellence (BCOE) showcase innovative strategies through real-world case studies, including the bioassay development of bispecific T-cell engagers and multi-specific probodies. Leveraging expertise in bioactivity method development, BCOE provides end-to-end CMC service and flexible standalone services…
Date:
More like thisRelated
Mergers and the Modern Board: A Credit Union Director’s Playbook
Credit union mergers have evolved from rescues to strategic...
Veracode Market Report by TrustRadius
In today’s landscape of escalating cyber threats, organizations need...
Top 10 OWASP Security Risks for AI Generated Code
Understanding the potential risks associated with AI integration is...